Outlook Therapeutics, Inc. (OTLK): NT 10-Q filed Aug 17, 2026

Form type

NT 10-Q

Filing date

Aug 17, 2026

Accession number

0001104659-26-097838

Filer

Outlook Therapeutics, Inc. (CIK 1649989)